Knight Therapeutics, headquartered in Montreal, restated an 'outperform' rating on its shares while operating in Mexico and LatAm.
2 reports, 2 independent
Updated Aug 6
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Knight Therapeutics, headquartered in Montreal, restated an 'outperform' rating on its shares while operating in Mexico and LatAm.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Company benefits from LATAM currency appreciation and Canadian business contributions.1 source
Knight Therapeutics received an 'outperform' rating restatement, involving Royal Bank of Canada.1 source
Keep exploring
The entities involved
-
Knight Therapeutics
Canadian pharmaceutical company
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
Related events
- Morgan Advanced Materials (UK-based company) is the subject of analyst rating updates from Royal Bank of Canada and Berenberg Bank.
- Royal Bank of Canada is headquartered in Toronto.
- Royal Bank of Canada rated Randstad shares, which operates in the Netherlands, with MarketBeat reporting on the stock.
- Royal Bank of Canada raised its shares rating for Lsb Industries on September 21, 2026.